For the Inventor, By the Inventor

Enter inventor name

Wilmington, DE, United States of America

Barry A Springer

USPTO Granted Patents = 13 (Patent Applications = 1)

Average Co-Inventor Count = 4.5

ph-index = 6

Forward Citations = 331(Granted Patents)

Company Filing History:

3-dimensional Pharmaceuticals, Inc.

Janssen Pharmaceutica Nv

Years Active: 2001-2017

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9815790 - Chemically modified quinoline and quinolone derivatives useful as CB-1 inverse agonists (2017-11-14),

2. 8883473 - Methods of treatment using allosteric processing inhibitors for matrix metalloproteinases (2014-11-11),

3. 8798939 - Methods for designing, selecting and/or optimizing allosteric processing inhibitors for matrix metalloproteinases (2014-08-05),

4. 8753857 - Crystal structure of the pro form of a matrix metalloproteinase and an allosteric processing inhibitor (2014-06-17),

5. 7138374 - Methods of using analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamate 89, asparate 101 or leucine 137 (2006-11-21),

6. 6767722 - Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamate 89, Aspartate 101 or Leucine 137 (2004-07-27),

7. 6737404 - Methods of using analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamate 89, aspartate 101 or leucine 137 (2004-05-18),

8. 6569631 - Microplate thermal shift assay for ligand development using 5-(4″dimethylaminophenyl)-2-(4′-phenyl)oxazole derivative fluorescent dyes (2003-05-27),

9. 6291192 - Method for identifying conditions that facilitate recombinant protein folding (2001-09-18),

10. 6291191 - Microplate thermal shift assay for ligand development and multi-variable protein chemistry optimization (2001-09-18),

11. 6274712 - Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamute 89, aspartate 101 or leucine 137 (2001-08-14),

12. 6268158 - Method for determining conditions that facilitate protein crystallization (2001-07-31),

13. 6232085 - Method for determining conditions that stabilize proteins (2001-05-15),

Title: The Innovative Journey of Barry A. Springer

Introduction: Barry A. Springer, a prolific inventor based in Wilmington, DE, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Barry A. Springer holds several patents in various technological domains, including artificial intelligence, renewable energy, and medical devices. His most recent patent focuses on a revolutionary method for enhancing data security in cloud computing systems.

Career Highlights: With a career spanning over two decades, Barry A. Springer has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His work has not only revolutionized industries but has also improved the lives of many through his inventions.

Collaborations: Throughout his career, Barry A. Springer has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: Barry A. Springer's relentless pursuit of innovation and his passion for creating solutions to complex problems have solidified his position as a respected inventor in the technology sector. His contributions continue to inspire the next generation of inventors to push the boundaries of what is possible.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…